PLYX Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
0
0
Cost of Revenue
0
0
Gross Profit
0
0
Operating Expenses
1.4M
-29.5%
2.0M
R&D
719.0K
+5.9%
679.0K
SG&A
661.0K
-48.3%
1.3M
Operating Income
-1380000
+29.5%
-1958000
EBITDA
-1380000
+29.5%
-1958000
Net Income
-1380000
+45.8%
-2544000
EPS (Basic)
$-0.03
+40.0%
$-0.05
EPS (Diluted)
$-0.03
+40.0%
$-0.05
Shares (Diluted)
48.3M
+2.2%
47.2M
Polaryx Therapeutics (PLYX) โ€” Financials